Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 406 for multiple

Edit search filters
  1. A Phase 1 Study Evaluating CPI-0610 In Patients With Previously Treated Multiple Myeloma

    Scottsdale/Phoenix, AZ

  2. A Multi-center Trial To Evaluate Multiple Regimens In Metastatic Pancreatic Cancer

    Rochester, MN

  3. A Dose Finding Study Followed By A Safety And Efficacy Study For Patients With Multiple Myeloma Or Lymphoma

    Rochester, MN

  4. A Multi-centered, Double-blind, Randomized, Placebo-controlled Study Of TEV-56286 For The Treatment Of Multiple System Atrophy

    Rochester, MN

  5. Phase 1 Study To Evaluate The Safety Of ATA188 In Subjects With Progressive And Relapsing-Remitting Multiple Sclerosis

    Scottsdale/Phoenix, AZ

  6. A Study Of The Safety And Effectiveness Of ADS-5102 In Patients With Multiple Sclerosis And A Walking Impairment

    Rochester, MN

  7. Pembrolizumab, Lenalidomide, And Dexamethasone In Treating Patients With Newly Diagnosed Multiple Myeloma Eligible For Stem Cell Transplant

    Jacksonville, FL, Rochester, MN

  8. Antineuronal Antibody Positivity Prevalence and Predictors in Epilepsy With Different Risks of Autoimmune Epilepsy

    Rochester, MN

  9. A Study to Validate a Self-Report Measurement of Treatment Burden for People with Multiple Chronic Conditions

    Rochester, MN

  10. A Study Evaluating ABT-199 In Multiple Myeloma Subjects Who Are Receiving Bortezomib And Dexamethasone As Standard Therapy

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer